Describe any therapeutic target.
Synthara-1 designs the molecule.
Synthara-1 Model
Synthara-1 is a single end-to-end generative model that accepts plain-language descriptions and outputs validated therapeutic proteins — sequence, 3D structure, and binding scores — in under a second.
Trained on 200 million protein structures and paired with a curated library of therapeutic targets, Synthara-1 understands biology through mechanism, function, and disease context.
Read the technical report →Architecture · Synthara-1 end-to-end model
Research Applications
From oncology to rare vascular disease — built for the hardest targets in medicine.
01
Design checkpoint inhibitors, bispecifics, and tumor-targeting antibodies with specificity constraints embedded directly in your prompt.
02
Generate Tie2-activating antibodies, anti-VEGF candidates, and angiopoietin axis modulators for cancer, retinopathy, and sepsis.
03
Rapidly iterate cytokine blockers and receptor antagonists for IBD, rheumatoid arthritis, and inflammatory disease.
Join leading research teams using Synthara-1 to accelerate therapeutic discovery.